Live Breaking News & Updates on Reunion Neuroscience
Stay updated with breaking news from Reunion neuroscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
RE104 is a psychedelic prodrug that was safe and well tolerated by healthy participants in a phase 1 clinical trial. RE104 produced an effective response at 33 mg which will be the effective dose used in the phase 2 trial investigating its efficacy in the treatment of PPD. The Latest A first-in-human, double-blind phase 1 clinical trial funded by Reunion Neuroscience ....
AbbVie pens $2B+ next-gen psychedelic pact with Gilgamesh fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.
Lycia Therapeutics Lands $106M for Protein Degraders That Treat Autoimmune & Inflammatory Diseases medcitynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medcitynews.com Daily Mail and Mail on Sunday newspapers.